Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLA | P06280 | 1/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.62 |
| ▸ | IAPP | P10997 | 1/20 | 0.59 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.59 |
| ▸ | MMP1 | P03956 | 6/20 | 0.58 |
| ▸ | MMP2 | P08253 | 6/20 | 0.58 |
| ▸ | MMP9 | P14780 | 6/20 | 0.58 |
| ▸ | MAOA | P21397 | 1/20 | 0.58 |
| ▸ | MAOB | P27338 | 1/20 | 0.58 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.58 |
| ▸ | LCK | P06239 | 1/20 | 0.57 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.56 |
| ▸ | CDK1 | P06493 | 1/20 | 0.56 |
| ▸ | CDK4 | P11802 | 1/20 | 0.56 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.56 |
| ▸ | CCND1 | P24385 | 1/20 | 0.56 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.56 |
| ▸ | APP | P05067 | 1/20 | 0.56 |
| ▸ | P4HB | P07237 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL667195 | 1.00 | GLA (0.62) | GLATDP1IAPPPTGS1MMP1 | |
| SCHEMBL14441060 | 0.88 | GLA (0.72) | GLATDP1IAPPPTGS1APP | |
| SCHEMBL667567 | 0.84 | CYP2C9 (0.63) | MMP1MMP2MMP9MAOAMAOB | |
| SCHEMBL667568 | 0.84 | CYP2C9 (0.63) | MMP1MMP2MMP9MAOAMAOB | |
| SCHEMBL29405719 | 0.82 | NPSR1 (0.65) | MMP1MMP2MMP9MAOAMAOB | |
| SCHEMBL448904 | 0.82 | NPSR1 (0.65) | MMP1MMP2MMP9MAOAMAOB | |
| SCHEMBL442408 | 0.82 | NPSR1 (0.65) | MMP1MMP2MMP9MAOAMAOB | |
| SCHEMBL10504122 | 0.82 | NPSR1 (0.65) | MMP1MMP2MMP9MAOAMAOB | |
| SCHEMBL28498749 | 0.82 | MMP1 (0.53) | MMP1MMP2MMP9MAOAMAOB | |
| SCHEMBL30676338 | 0.81 | CA12 (0.66) | MMP1MMP2MMP9APPP4HB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9745240-B2 | Metal free process for allylic oxidation | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2017-08-29 | — | — | US | claimed |
| US-20160159717-A1 | NOVEL METAL FREE PROCESS FOR ALLYLIC OXIDATION | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2016-06-09 | — | — | US | claimed |
| EP-2847318-A1 | PESTICIDAL FLAVOBACTERIUM STRAIN AND BIOACTIVE COMPOSITIONS, METABOLITES AND USES | Marrone Bio Innovations, Inc. (US) | 2015-03-18 | — | — | EP | claimed |
| WO-2015015511-A1 | NOVEL METAL FREE PROCESS FOR ALLYLIC OXIDATION | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2015-02-05 | — | — | WO | claimed |
| US-20150031534-A1 | PESTICIDAL FLAVOBACTERIUM STRAIN AND BIOACTIVE COMPOSITIONS METABOLITES AND USES | PRO FARM GROUP, INC. | 2015-01-29 | — | — | US | claimed |
| WO-2013138398-A1 | PESTICIDAL FLAVOBACTERIUM STRAIN AND BIOACTIVE COMPOSITIONS, METABOLITES AND USES | MARRONE BIO INNOVATIONS, INC. (US) | 2013-09-19 | — | — | WO | claimed |
| US-20050080260-A1 | Preparation of prodrugs for selective drug delivery | LUMINIDE | 2005-04-14 | — | — | US | claimed |
| US-11746364-B2 | Enzymatic synthesis of kavalactones and flavokavains | WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) | 2023-09-05 | — | — | US | disclosed |
| US-11739354-B2 | Enzymatic synthesis of kavalactones and flavokavains | WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) | 2023-08-29 | — | — | US | disclosed |
| CN-113304129-B | Application of mono-ketene monocarbonyl curcumin analogue in preparing antioxidant drugs | 温州医科大学附属第二医院（温州医科大学附属育英儿童医院） | 2022-11-08 | — | — | CN | disclosed |
| US-20220289657-A1 | COMPOSITION FOR PREVENTING OR TREATING BACTERIAL INFECTIOUS DISEASE COMPRISING 4-GINGEROL DERIVATIVE COMPOUND AS ACTIVE INGREDIENT | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION, SEJONG CAMPUS (KR) | 2022-09-15 | — | — | US | disclosed |
| US-20210227833-A1 | PESTICIDAL FLAVOBACTERIUM STRAIN AND BIOACTIVE COMPOSITIONS METABOLITES AND USES | MARRONE BIO INNOVATIONS, INC. (US) | 2021-07-29 | — | — | US | disclosed |
| US-20210227833-A1 | PESTICIDAL FLAVOBACTERIUM STRAIN AND BIOACTIVE COMPOSITIONS METABOLITES AND USES | MARRONE BIO INNOVATIONS, INC. (US) | 2021-07-29 | — | — | US | disclosed |
| WO-1991015119-A1 | SUBSTITUTED CYCLOHEXANEDIONES AND THEIR HERBICIDAL USES | DOWELANCO (US) | 1991-10-17 | — | — | WO | disclosed |
| EP-0450711-A1 | Substituted cyclohexanediones and their herbicidal uses | DOWELANCO (US) | 1991-10-09 | — | — | EP | disclosed |
| EP-0449385-A2 | Substituted cyclohexanediones and their herbicidal uses | DOWELANCO (US) | 1991-10-02 | — | — | EP | disclosed |
| US-5006159-A | Oximes, effective against grassy weeds but selective to broadleaf crops such as cotton, sugar beets, soybeans, wheat, rice and corn | DOWELANCO (US) | 1991-04-09 | — | — | US | disclosed |
| EP-0414730-A1 | LUMINIDE AND MACROLUMINIDE CLASS OF PHARMACEUTICALS | Mills, Randell L. (US) | 1991-03-06 | — | — | EP | disclosed |
| US-4983211-A | Substituted cyclohexanediones and their herbicidal use | DOWELANCO (US) | 1991-01-08 | — | — | US | disclosed |
| WO-1989009833-A1 | LUMINIDE AND MACROLUMINIDE CLASS OF PHARMACEUTICALS | MILLS RANDELL L (US) | 1989-10-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050080260-A1 | Preparation of prodrugs for selective drug delivery | APEH, PAH, ALAD | GLA 2436/4885TDP1 2098/4885IAPP 2768/4885 |
| US-20160159717-A1 | NOVEL METAL FREE PROCESS FOR ALLYLIC OXIDATION | NFE2L2, PPOX, NOX4 | GLA 2646/4885TDP1 4878/4885IAPP 4681/4885 |
| US-20210227833-A1 | PESTICIDAL FLAVOBACTERIUM STRAIN AND BIOACTIVE COMPOSITIONS METABOLITES AND USES | BLVRB, PRDX6, ACHE | GLA 1620/4885TDP1 1630/4885IAPP 1262/4885 |
| US-20220289657-A1 | COMPOSITION FOR PREVENTING OR TREATING BACTERIAL INFECTIOUS DISEASE COMPRISING 4-GINGEROL DERIVATIVE COMPOUND AS ACTIVE INGREDIENT | HSD11B1, GRHPR, TIPRL | GLA 535/4885TDP1 4802/4885IAPP 4478/4885 |
| US-20150031534-A1 | PESTICIDAL FLAVOBACTERIUM STRAIN AND BIOACTIVE COMPOSITIONS METABOLITES AND USES | BLVRB, PRDX6, ACHE | GLA 1620/4885TDP1 1630/4885IAPP 1262/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.